Results 91 to 100 of about 47,760 (259)

Peri-operative pharmacokinetics of cefazolin prophylaxis during valve replacement surgery.

open access: yes, 2023
ObjectiveThere is little prospective data to guide effective dosing for antibiotic prophylaxis during surgery requiring cardiopulmonary bypass (CPB).
Jason A Roberts   +8 more
core   +1 more source

Urban ants as potential mechanical vectors of pathogenic and antibiotic‐resistant bacteria in a Brazilian hospital

open access: yesMedical and Veterinary Entomology, EarlyView.
Nine ant taxa were identified in a Brazilian hospital, with Tapinoma melanocephalum and Dorymyrmex brunneus being the most abundant. Eighty‐five percent of collected ants yielded detectable bacterial growth, including clinically relevant genera such as Acinetobacter, Pseudomonas, Escherichia coli and Pluralibacter.
Luana Biggi Souza   +10 more
wiley   +1 more source

A Comparative Evaluation of Risk Factors and Various Antibiotic Regimens in Postoperative Neurosurgical Infections: A Prospective Randomized Controlled Study

open access: yesIndian Journal of Neurosurgery, 2017
Introduction Postoperative neurosurgical infections are a major problem, and the importance of keeping them to an absolute minimum cannot but be overemphasized.
R. Shetty   +4 more
doaj   +1 more source

Comparative outcomes of cefazolin versus anti-staphylococcal penicillins in methicillin-susceptible Staphylococcus aureus infective endocarditis: a post-hoc analysis of a prospective multicentre French cohort study.

open access: yesClinical Microbiology and Infection, 2020
OBJECTIVES Current guidelines recommend cefazolin as an alternative to anti-staphylococcal penicillins (ASPs) in methicillin-susceptible Staphylococcus aureus (MSSA) infective endocarditis despite the lack of comparative study.
R. Lecomte   +11 more
semanticscholar   +1 more source

Cefazolin potency against methicillin-resistant Staphylococcus aureus: a microbiologic assessment in support of a novel drug delivery system for skin and skin structure infections

open access: yes, 2017
David P Nicolau,1 Barry N Silberg2 1Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT, USA; 2Department of Surgery, Sonoma West Medical Center, Sebastopol, CT, USA Introduction: Despite aggressive medical and surgical ...
Nicolau DP, Silberg BN
core  

Hepatic cyst penetration of cefazolin in patients receiving aspiration sclerotherapy

open access: yes, 2016
Item does not contain fulltextBACKGROUND: Hepatic cyst infection is a potentially severe complication in cystic disease. Treatment demands effective antibiotic concentrations within the infected cyst. OBJECTIVES: The aim of this study was to use elective
Burger, D.M.   +7 more
core   +1 more source

First Experience With Extravascular Implantable Cardioverter‐Defibrillator Under Deep Sedation

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background The Extravascular Implantable Cardioverter‐Defibrillator (EV‐ICD) utilizes a substernal lead to provide defibrillation and anti‐tachycardia pacing (ATP) while avoiding transvenous complications. General anesthesia (GA) was applied for implantation procedures in the EV‐ICD pivotal trial and is currently recommended by the ...
Nibras Soubh   +9 more
wiley   +1 more source

Prophylactic Antibiotic Choice and Deep Infection in Lower Extremity Endoprosthetic Reconstruction: Comparison of Cefazolin, Cefazolin-Vancomycin, and Alternative Regimens

open access: yes
INTRODUCTION: Infection is a common mode of failure in lower extremity endoprostheses. The Prophylactic Antibiotic Regimens in Tumor Surgery trial reported that 5 days of cefazolin had no difference in surgical site infection compared with 24 hours of ...
Mika, Aleksander P   +13 more
core   +1 more source

CLINICAL EXPERIENCE OF CEFAZOLIN IN UROLOGICAL INFECTIONS [PDF]

open access: yes, 1972
Cefazolin was administered to 55 patients with various urinary tract infections at a daily dose of 1.0 g to 2.0 g for a week. Satisfactory results were obtained in 84 % of the cases treated with 1.0 g and in 88.2 % of the cases treated with 2.0 g both in
鈴木, 良二
core  

Pharmacokinetics of Intraperitoneal Cefazolin and Ceftazidime Coadministered to CAPD Patients

open access: yes, 2005
PurposeGuidelines for empiric treatment of PD-related peritonitis published in 2000 recommend concurrent intraperitoneal (IP) cefazolin and ceftazidime. The pharmacokinetics (PK) of these agents combined have not been studied.
R.J. Elwell   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy